Jim Cramer was right. He was just a bit premature.
In January, 2012, when Cramer introduced Zeltiq Aesthetics (ZLTQ) to his rabid following, he made some heady comparisons between Zeltiq and monster-stock, Intuitive Surgical (ISRG). While the two medical technology companies operate in different spheres of the healthcare industry, after ZLTQ's breakout Q3 report on October 30th, we note the two names do share some amazing similarities in terms of their early growth stories.
In 2003, Intuitive Surgical offered its first major upgrade to its robotic surgical da Vinci System and sales proceeded to skyrocket the following year. In much the same way, we believe Zeltiq's CoolSculpting® procedure, for the reduction of unsightly...
Only subscribers can access this article, which is part of the PRO research library covering 3,553 different stocks.
Growing numbers of fund managers and other investment professionals subscribe to Seeking Alpha PRO for equity research that is unavailable elsewhere, so they can: